Show items per page
Elements: 111
Page 1 on 6
 TitleAuthors / EditorsDate
add to browser selection
Assessing aspirin responsiveness using the Verify Now Aspirin assay Fontana, Pierre; Reber, Guido; De Moerloose, Philippe 2008
add to browser selection
Aspirin "resistance" and risk of cardiovascular morbidity Fontana, Pierre; De Moerloose, Philippe; Gris, J-C.; Reny, Jean-Luc 2008
add to browser selection
Laboratory-defined aspirin resistance and recurrent cardiovascular events Fontana, Pierre; Reny, Jean-Luc 2008
add to browser selection
Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness Fontana, Pierre; Senouf, David; Mach, François 2008
add to browser selection
Impending paradoxical embolism. When and how to treat? Bonvini, Robert; Robert-Ebadi, Helia; Fontana, Pierre; Fassa, A.; ... Righini, M. 2008
add to browser selection
Aspirin response variability assessed with the PFA-100 device Reny, Jean-Luc; Quéré, Isabelle; De Moerloose, Philippe; Fontana, Pierre 2008
add to browser selection
Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis Reny, Jean-Luc; De Moerloose, Philippe; Dauzat, M.; Fontana, Pierre 2008
add to browser selection
Intercellular communication in atherosclerosis Burnier, Laurent; Fontana, Pierre; Angelillo-Scherrer, Anne; Kwak, Brenda 2009
add to browser selection
Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance Bonvini, Robert; Reny, Jean-Luc; Mach, François; Zeller, Thomas; Fontana, Pierre 2009
add to browser selection
Cell-derived microparticles in haemostasis and vascular medicine Burnier, Laurent; Fontana, Pierre; Kwak, Brenda; Angelillo-Scherrer, Anne 2009
add to browser selection
Diagnosis of mild bleeding disorders De Moerloose, Philippe; Levrat, Emmanuel; Fontana, Pierre; Boehlen, Françoise 2009
add to browser selection
Platelet hyperreactivity and dual antiplatelet therapy: can biases be avoided? Fontana, Pierre; De Moerloose, Philippe; Reny, Jean-Luc 2009
add to browser selection
Le concept de "resistance" a l'aspirine: mecanismes et pertinence clinique Reny, Jean-Luc; Bonvini, Robert; Barazer, I.; Berdague, P.; ... Fontana, Pierre 2009
add to browser selection
No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro Gaussem, Pascale; Ishida, Brian Y.; Fontana, Pierre; Pullinger, Clive R.; ... Gandrille, Sophie 2009
add to browser selection
Antiagregants plaquettaires : lequel, quand et pour qui ? Reny, Jean-Luc; Zufferey, A.; Berdague, P.; Fontana, Pierre 2010
add to browser selection
Clinical implications of clopidogrel non-response in cardiovascular patients: a systematic review and meta-analysis Combescure, Christophe; Fontana, Pierre; Mallouk, N.; Berdague, P.; ... Reny, Jean-Luc 2010
add to browser selection
Maladies cardiovasculaires, antiagrégants, anticoagulants et risque hémorragique Eusebio, Jorge; Reny, Jean-Luc; Fontana, Pierre; Nendaz, Mathieu 2010
add to browser selection
Hémostase. Le point sur les nouveaux antithrombotiques Boehlen, Françoise; Tirefort-Dimitrova, Y.; De Moerloose, Philippe; Fontana, Pierre 2010
add to browser selection
Evaluation de l'efficacité biologique du clopidogrel: génotype ou phénotype? Fontana, Pierre; Bonvini, Robert; Roffi, Marco; Boehlen, Françoise; ... Reny, Jean-Luc 2010
add to browser selection
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study Fontana, Pierre; Berdague, P.; Castelli, C.; Nolli, S.; ... Reny, Jean-Luc 2010
<< previous | 1 | 2 | 3 | 4 | 5 | 6 |